Click Therapeutics is one company working in this field, providing prescription software as a treatment for patients with unmet and high-burden needs such as chronic pain, major depressive disorder and migraines. There are other companies working in this area such as OurPath, Soma, and Ieso, but the global digital therapeutics market is estimated to be worth up to $18 billion by 2027 and is still largely untapped, leaving plenty of room to grow.

Click Therapeutics has raised funding through several investment rounds and debt financing. It is using this capital to accelerate the development of its products and further improve the performance of its platform. As the efficacy of digital therapeutics becomes more widely-known, Click Therapeutics is in a strong position to grow.